Ibtrozi

Taletrectinib · Nuvation Bio Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)

Ibtrozi ingredients

Active ingredientStrength
Taletrectinib Adipate272 mg/1

What Ibtrozi is used for

Ibtrozi is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Ibtrozi
Generic name
Taletrectinib
Made by
Nuvation Bio Inc.
Forms
Capsule
Given
Oral
Drug class
Kinase Inhibitor
FDA approval
New drug application (NDA) NDA219713
On the US market since
2025

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Ibtrozi?

Ibtrozi (Taletrectinib) is a cancer medicine made by Nuvation Bio Inc., approved by the US FDA.

What are the ingredients of Ibtrozi?

Ibtrozi contains Taletrectinib Adipate (272 mg/1).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.